Viruses are one of the most common causes of elevated liver enzymes, and the list of viruses capable of doing this extends well beyond the hepatitis family. Hepatitis A through E are the best-known offenders, but Epstein-Barr virus, cytomegalovirus, dengue, and SARS-CoV-2 can all push liver enzymes above normal ranges. The pattern and degree of elevation vary widely depending on the virus involved, and understanding which virus is responsible often changes how doctors interpret the numbers and what they do next.
The Hepatitis Viruses and What They Do to Liver Enzymes
The five hepatitis viruses (A, B, C, D, and E) are named for their tendency to target the liver directly, and they remain the first suspects when a blood test comes back with abnormal liver enzymes. But the degree of enzyme elevation depends heavily on which hepatitis virus is involved and whether the infection is acute or chronic.
In uncomplicated acute hepatitis A and B, ALT and AST levels commonly soar above 1,000 U/L, with ALT running higher than AST. Hepatitis C, by contrast, tends to produce only moderate elevations. Most patients with chronic viral hepatitis from any of these viruses have relatively mild enzyme bumps, generally under 100 U/L, and those levels can fluctuate over time rather than staying consistently high.1Journal of Clinical and Translational Hepatology. Elevated Liver Enzymes in Asymptomatic Patients – What Should I Do? Hepatitis A and E tend to produce more dramatic shifts in liver enzymes and bilirubin than hepatitis B and C, partly because A and E infections are almost always acute, while B and C frequently become chronic.2IJAERS Journal. The Impacts of Viral Hepatitis on Liver Enzymes and Bilrubin
The distinction between acute and chronic matters for interpretation. A person with chronic hepatitis B can have a normal ALT for months or years and still carry high levels of the virus with significant liver damage happening quietly underneath. Recent data have raised real concerns about relying on ALT alone for treatment decisions, because a meaningful proportion of chronic hepatitis B patients with normal ALT have active viral replication and liver injury visible on biopsy.3PubMed Central. Should chronic HBV infected patients with normal ALT treated: debate So a normal enzyme level does not always mean the liver is fine when a chronic virus is involved.
Chronic hepatitis B can also produce sudden flares, defined as an abrupt spike in ALT to more than five times the upper limit of normal. These flares are driven by the immune system mounting a sudden attack against virus-infected liver cells. The clinical picture ranges from no symptoms at all to full-blown acute hepatitis with jaundice, and in severe cases, the liver can decompensate.4PubMed. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management These flares are a reminder that even a “stable” chronic hepatitis B infection can suddenly produce alarming enzyme numbers.
Viruses That Are Not Hepatitis but Still Affect the Liver
Many people are surprised to learn that viruses with no “hepatitis” in their name routinely cause liver enzyme elevations. Two of the most common are Epstein-Barr virus (EBV) and cytomegalovirus (CMV), both members of the herpesvirus family. In infectious mononucleosis caused by EBV, AST was abnormal in about 97% of patients studied serially, and alkaline phosphatase was elevated in about 94%. CMV-related mono showed similar trends, with AST elevated in about 88% and alkaline phosphatase in about 64%.5Clinical Chemistry. Hepatic function in mononucleosis induced by Epstein-Barr virus and cytomegalovirus The enzyme bumps from EBV and CMV are typically mild to moderate, and very high levels (above 1,000 U/L) actually argue against these viruses as the cause.
Dengue is another major culprit, especially in tropical and subtropical regions. Liver enzyme elevations are the rule rather than the exception in dengue, and the pattern is distinctive: AST tends to rise more than ALT, which is the reverse of what you see in most hepatitis virus infections. A large meta-analysis found AST abnormalities in roughly 75–80% of dengue cases, compared to 50–55% for ALT. Elevated AST, rather than ALT, has been linked more strongly with progression to severe dengue.6PubMed Central. Elevated liver enzyme (AST and ALT) as biomarkers for severe dengue in Nepalese patients: a cross-sectional study
SARS-CoV-2, the virus behind COVID-19, also causes liver damage and elevated transaminase levels. This was recognized early in the pandemic as part of the multiorgan damage COVID-19 can inflict.7PubMed Central. Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments Even mild or asymptomatic Omicron infections can disturb liver enzymes. A retrospective study found that about 28% of patients with asymptomatic or mild Omicron had at least one abnormal liver function marker. Males had higher rates of abnormality, and patients with abnormal liver enzymes also showed higher levels of inflammatory markers.8PubMed Central. Altered Liver Enzyme Markers in Patients with Asymptomatic, and Mild Omicron Infection: A Retrospective Study
Why the Pattern of Elevation Matters
When doctors see abnormal liver enzymes, one of the first things they do is categorize the pattern. An elevation dominated by ALT and AST points toward liver-cell damage, called a hepatocellular pattern. When alkaline phosphatase is the main abnormality, that suggests a problem with bile flow, called a cholestatic pattern. Many conditions produce a mix of both.9Clinics in Liver Disease. Evaluation of Elevated Liver Enzymes
Different viruses tend to produce different patterns, and this can help narrow the diagnosis. Classic acute hepatitis A or B produces a dramatic hepatocellular pattern with ALT and AST well into the thousands. EBV and CMV tend to cause a more mixed picture, with alkaline phosphatase and GGT elevated alongside moderate AST rises. The Omicron COVID-19 study found that the cholestatic pattern was actually the most common type of liver enzyme disturbance in mild infections, affecting about 16% of patients, while a pure hepatocellular pattern occurred in about 5%.8PubMed Central. Altered Liver Enzyme Markers in Patients with Asymptomatic, and Mild Omicron Infection: A Retrospective Study
The ratio between AST and ALT also carries prognostic weight. In chronic hepatitis C, the AST-to-ALT ratio, combined with platelet count, achieved a positive predictive value of 97% and a negative predictive value of about 98% for diagnosing cirrhosis. A high AST-to-ALT ratio also had reasonable sensitivity for identifying cirrhotic patients at risk of dying within one year.10JAMA Internal Medicine. Validity and Clinical Utility of the Aspartate Aminotransferase–Alanine Aminotransferase Ratio in Assessing Disease Severity and Prognosis in Patients With Hepatitis C Virus–Related Chronic Liver Disease So the same enzymes that signal a virus is present can also signal how much permanent damage the liver has already sustained.
The Acetaminophen Complication
One of the trickiest aspects of interpreting liver enzymes during a viral illness is that the medications people take for symptoms can independently raise those same enzymes. Acetaminophen (paracetamol) is the most important example. Many people reach for it during fevers from flu, dengue, or other viral infections, but the combination of a liver already stressed by a virus plus acetaminophen can amplify the damage.
A randomized, placebo-controlled trial in dengue patients found that those given paracetamol had substantially higher daily increases in both AST and ALT compared to the placebo group. By recovery day, the risk of transaminase elevation was more than five times greater in the paracetamol group. The researchers estimated that for every eight dengue patients treated with paracetamol, one would develop abnormal transaminase levels that would not have occurred otherwise.11The Lancet. Safety and efficacy of paracetamol in dengue infection in Thailand: a randomised, double-blind, placebo-controlled trial A separate study found that consuming more than 8 grams of acetaminophen orally during a dengue infection more than quadrupled the odds of transaminase levels rising above three times normal.12PubMed. Is excessive acetaminophen intake associated with transaminitis in adult patients with dengue fever?
The overlap between viral and drug-induced liver injury also matters when infections become severe. In patients with viral hepatitis who developed acute liver failure, those with higher acetaminophen exposure had significantly higher AST and ALT levels than those with no exposure. Interestingly, the biochemical profile of these combined-injury patients fell between what you would see in pure acetaminophen overdose and pure viral hepatitis, suggesting the two insults amplify each other in a distinct way.13PubMed Central. Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in Patients with Viral Hepatitis-Associated Acute Liver Failure The practical takeaway: if you have a viral infection that targets the liver, even standard doses of acetaminophen deserve caution, and exceeding recommended doses is genuinely risky.
When Liver Enzymes Stay Elevated After the Virus Clears
Most acute viral infections resolve and liver enzymes drift back to normal within weeks. In acute hepatitis A and B, ALT typically declines slowly and gradually over several weeks after the acute phase passes.1Journal of Clinical and Translational Hepatology. Elevated Liver Enzymes in Asymptomatic Patients – What Should I Do? But some viruses leave a longer mark. In long COVID patients, markers of liver injury were found to persist for more than a year and a half after the initial infection resolved.14PubMed Central. Liver Function in Patients with Long-Term Coronavirus Disease 2019 of up to 20 Months: A Cross-Sectional Study
Chronic hepatitis B and C are the most significant examples of persistent enzyme elevation because the virus itself persists. As discussed earlier, chronic hepatitis B can simmer at low enzyme levels for years and then flare unpredictably. Hepatitis C was historically the most common cause of chronically elevated transaminases until effective antiviral treatments became available. Even after successful treatment, the liver may take time to fully normalize its enzyme output, depending on how much fibrosis accumulated during the years of chronic infection.
When Viral Liver Injury Turns Dangerous
In most people, viral liver enzyme elevations are temporary and self-limiting. But in a small fraction, viral hepatitis progresses to acute liver failure, a medical emergency. The hepatitis viruses most commonly linked to fulminant liver failure are hepatitis A, B, and dual B/D infection. Hepatitis C, interestingly, almost never causes fulminant courses. Hepatitis E can also cause acute liver failure, though it has received less attention historically.15PubMed Central. Liver Failure due to Acute Viral Hepatitis (A-E)
Hepatitis E deserves special mention for pregnant women and immunocompromised individuals, groups in which it carries disproportionate risk. In one study of acute hepatitis E, patients who tested positive for HEV antigen had significantly higher ALT, AST, alkaline phosphatase, and GGT than antigen-negative patients, suggesting that ongoing viral replication drives more intense liver damage.16PubMed. Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E
Immunocompromised Patients and Children
The immune system’s strength shapes how viruses affect the liver. In people with weakened immunity, viruses that barely bother healthy livers can cause serious hepatitis. CMV is a clear example: in people with healthy immune systems, CMV infection usually produces mild or no liver symptoms, but in immunocompromised patients, particularly those who have received liver transplants, it often causes clinically significant hepatitis.17PubMed Central. Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts Similarly, EBV reactivation causing isolated cholestatic hepatitis is extremely rare in the general population but has been reported in immunocompromised patients.18PubMed Central. Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis
In infants and young children, mildly elevated liver enzymes are a fairly common finding that sometimes turns out to be caused by CMV. In one study of young children investigated for prolonged, isolated aminotransferase elevation lasting more than three months, six children were found to have positive CMV antigen in urine and were analyzed separately. Among the remaining 72 children, the average duration of elevated enzymes was about 12 months, and the condition was largely benign, resolving on its own without treatment. The initial average ALT was about 86 IU/L, peaking around 141 IU/L, then settling back to about 40 IU/L.19Archives of Disease in Childhood. The significance of isolated elevation of serum aminotransferases in infants and young children For parents whose child is found to have mildly elevated enzymes during a routine check, the reassuring news is that in otherwise healthy-looking children, this usually resolves within a year without needing aggressive investigation.
COVID-19 Vaccines and Liver Enzymes
Since COVID-19 itself can elevate liver enzymes, a natural question is whether COVID-19 vaccines do the same. The short answer: very rarely. Among more than 470,000 vaccinated individuals in one large study, only 177 (about 0.04%) met criteria for liver injury after SARS-CoV-2 vaccination. Most cases occurred after the second dose, and the average time to injury was about 45 days after the second shot. The liver injury pattern was hepatocellular in 45% of cases. Among patients with follow-up data, about half had their liver tests normalize.20PubMed Central. Unexplained liver test elevations after SARS-CoV-2 vaccination Notably, the rate of liver injury after SARS-CoV-2 vaccination was actually lower than after influenza vaccination in the same study.
A small subset of post-vaccination liver injuries showed features of immune-mediated hepatitis, where the immune system, revved up by the vaccine, appears to attack liver cells. In a large case series, 57% of patients with post-vaccination liver injury showed these immune-mediated features. The liver injury pattern was hepatocellular in 84% of those cases. Nearly all patients recovered, though one individual developed liver failure requiring transplantation.21PubMed Central. Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome The overall risk of hepatotoxicity from COVID-19 vaccines is comparable to that of other commonly administered vaccines, and these transient enzyme elevations are thought to reflect the immune response to the vaccine rather than a direct toxic effect on the liver.22Gastroenterology & Endoscopy. Impact of COVID-19 vaccines on liver function: A state of the art and challenges for healthcare providers
When a Virus Is Not Actually the Explanation
Because elevated liver enzymes are so common during viral illnesses, there is a real risk of attributing the elevation to the virus when something else is responsible. Alcohol use, fatty liver disease, autoimmune conditions, and medications (including antibiotics, statins, and herbal supplements) can all raise liver enzymes and may coincide with a viral illness. A person who develops a fever, takes multiple over-the-counter medications, and gets blood work showing elevated enzymes might have liver enzyme elevations driven more by the drugs than by the virus itself.
Herbal and dietary supplements are a particularly underappreciated contributor. Among HIV-positive patients attending a clinic, about 22% reported using one or more herbal products, and several were taking them at doses where the literature identified potential adverse effects including liver toxicity.23JAMA Internal Medicine. The Use of Medicinal Herbs by Human Immunodeficiency Virus-Infected Patients People with chronic viral infections who are also taking supplements may have their enzyme elevations wrongly blamed on the virus when the supplement is doing the damage, or vice versa. Teasing apart the contributions of a virus, medications, supplements, and underlying liver conditions is one of the genuine diagnostic challenges clinicians face, and it is why the answer to “is this from the virus?” is often “probably, but let’s make sure.”
The diagnostic workup usually starts with the pattern of enzyme elevation, moves to specific viral serologies (antibody and antigen tests for hepatitis viruses, EBV, CMV, and others as indicated), and layers on imaging and sometimes biopsy if the picture remains unclear. A full medication and supplement history is just as important as the viral testing, because the treatment approach changes entirely depending on whether the liver injury is viral, drug-induced, or both.